EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
4.2.1.2 | citrylpolymethylenediamine | - |
Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
4.2.1.2 | Sus scrofa | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
4.2.1.2 | affinity chromatography with Sepharose derivatives containing citric acid. The purification is dependent on the length of the spacer arm, but not on the isomeric configuration of the immobilized citrate | Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
4.2.1.2 | heart | - |
Sus scrofa | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
4.2.1.2 | additional information | - |
- |
Sus scrofa |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.2.1.2 | (S)-malate | - |
Sus scrofa | fumarate + H2O | - |
? |